Similar to previous findings (Ligon et al., 2004), Olig2 immunoreactivity was observed in all cases of GBM (Trépant et al., 2015) and was primarily nuclear with rare cases exhibiting cytoplasmic Olig2 staining. Here, OLIG2 is linked to glioblastoma.